Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.31 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10779512 | 0.85 | — | — | |
| SCHEMBL10779518 | 0.85 | — | — | |
| SCHEMBL5837081 | 0.83 | MGAM (0.41) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL3504118 | 0.82 | NAAA (0.36) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL4216699 | 0.82 | NAAA (0.36) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL4216701 | 0.82 | NAAA (0.36) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL10718835 | 0.80 | TSHR (0.33) | — | |
| SCHEMBL10733049 | 0.80 | TSHR (0.33) | — | |
| SCHEMBL20646268 | 0.80 | TSHR (0.46) | SOAT1 | |
| SCHEMBL2146119 | 0.78 | ALDH1A1 (0.41) | CNR2CNR1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5686424-A | FOR TREATING INFLAMMATION | MILES INC. (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | disclosed |